Dihydroergotamine Mesylate and Palifermin Intravenous
Determining the interaction of Dihydroergotamine Mesylate and Palifermin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: palifermin
Brand name: Kepivance
Synonyms: Palifermin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Paliperidone
- Dihydroergotamine Mesylate-Paliperidone Extended-Release Tablets
- Dihydroergotamine Mesylate-Paliperidone injection
- Dihydroergotamine Mesylate-Paliperidone Intramuscular
- Dihydroergotamine Mesylate-Palladone
- Dihydroergotamine Mesylate-Palmitate-A
- Palifermin Intravenous-Dihydroergotamine nasal
- Palifermin Intravenous-Dihydroergotamine Nasal Spray
- Palifermin Intravenous-Dilacor XR
- Palifermin Intravenous-Dilantin
- Palifermin Intravenous-Dilantin Infatabs
- Palifermin Intravenous-Dilantin injection